Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 70518-4456

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70518-4456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Metoprolol succinate 100 mg tablet label for 90 tablets. The label shows it is a film-coated, extended-release oral tablet, repackaged by RemedyRepack Inc., Indiana. It includes storage instructions, manufacturer details (Northstar Rx LLC, Memphis, TN), and a white round tablet imprint 'M;3.' The label states 'RX ONLY.'*
FDA Label Image

Figure (Figure)

Figure (Figure)
A forest plot titled 'Results for Subgroups in MERIT-HF' displaying relative risk and 95% confidence intervals for three outcomes: Total Mortality, Total Mortality or All-Cause Hospitalization (Time to First Event), and Total Mortality or Hospitalization for Heart Failure (Time to First Event). The plot compares metoprolol succinate extended-release tablets versus placebo across various subgroups including geographic regions, NYHA class, ejection fraction categories, ischemic etiology, sex, race, myocardial infarction history, diabetes mellitus, hypertension, and heart rate. Each outcome features a horizontal axis measuring relative risk from 0 to 2, with markers indicating favoring metoprolol or placebo. Additional footnotes define abbreviations used in the chart.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of metoprolol succinate shown as two distinct parts, representing the metoprolol moiety and the succinate moiety in a combined molecular form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.